Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 361380 of 20,252 grants

Active NON-SBIR/STTR RPGS
IRS2 and mitotic regulation in breast cancer
NATIONAL CANCER INSTITUTE University of Massachusetts Med Sch Worc... United States 2024 – 2029

Project Summary The overall goal of this proposal is to determine the mechanism by which Insulin Receptor Substrate 2 (IRS2) regulates the spindle assembly checkpoint (SAC) and to...

$5.34M
USD
Active NON-SBIR/STTR RPGS
Mechanisms Driving the Rapid Evolution of Cancer Genomes
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2031

PROJECT SUMMARY/ABSTRACT The goal of this proposal is to identify the mechanism of catastrophic mutational processes that drive very rapid evolution of cancer genomes. One of these...

$9.42M
USD
Active NON-SBIR/STTR RPGS
Radiation and dendritic cell combination to improve immunotherapy response in intrahepatic cholangiocarcinoma
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2024 – 2029

Summary Intrahepatic cholangiocarcinoma (iCCA), the second most common primary liver cancer after hepatocellular carcinoma (HCC), is an aggressive malignancy with dismal overall pr...

$6.11M
USD
Active NON-SBIR/STTR RPGS
Stromal targeting to improve the efficacy of systemically administered drugs for pancreatic ductal adenocarcinomas
NATIONAL CANCER INSTITUTE Purdue University United States 2024 – 2029

Project Summary Only about 20% of pancreatic ductal adenocarcinoma (PDAC) patients are expected to survive one year from diagnosis, with the overall 5-year survival rate reported a...

$5.99M
USD
Active OTHER RESEARCH-RELATED
Development of a novel survey to screen for chemotherapy-induced peripheral neuropathy in young children
NATIONAL CANCER INSTITUTE Yale University United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT This application is developed to support Rozalyn Rodwin, MD, MHS, a current Assistant Professor in Pediatric Hematology-Oncology at Yale School of Medicine...

$2.56M
USD
Active NON-SBIR/STTR RPGS
Decreasing Cardiometabolic Risk in Survivors of Childhood Cancer: Survivors engaged in Time-Restricted EatiNG after THerapy (STRENGTH)
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2029

PROJECT SUMMARY Over 500,000 survivors of childhood cancer are living in the United States today. Cardiovascular disease is the leading cause of noncancer late mortality in this co...

$7.95M
USD
Active NON-SBIR/STTR RPGS
Molecular Mechanisms Underlying Luminal- Neuroendocrine Transdifferentiation
NATIONAL CANCER INSTITUTE Emory University United States 2024 – 2029

Summary The objective of this proposal is to determine the molecular mechanisms underlying luminal-to-neuroendocrine transdifferentiation (NET) of prostate cancer (PCa). NET underl...

$5.41M
USD
Active NON-SBIR/STTR RPGS
3D Spatial Multi-Omics Profiling of Ovarian Cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

Research Summary: High-grade serous ovarian cancer (HGSOC) is the most common histologic subtype of ovarian cancer. Despite ongoing efforts to develop effective surgical and treatm...

$10.05M
USD
Active NON-SBIR/STTR RPGS
Center for Human Lymphoma Spatiotemporal Atlas (HuLymSTA)
NATIONAL CANCER INSTITUTE Yale University United States 2024 – 2029

SUMMARY Non-Hodgkinlymphomas (NHL) represent about 90% of all lymphomas diagnosed each year and is classified based on cell type - B cell, T cell and natural killer (NK) cell types...

$10.19M
USD
Active NON-SBIR/STTR RPGS
Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D)
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

PROJECT SUMMARY This application aims to address the urgent need for precision in intercepting hereditary diffuse gastric cancer (HDGC) associated with pathogenic germline CDH1 mut...

$10.7M
USD
Active NON-SBIR/STTR RPGS
A Multimodal 3D Atlas of Colorectal Cancer Across Ages of Onset
NATIONAL CANCER INSTITUTE Vanderbilt University United States 2024 – 2029

PROJECT SUMMARY We propose the construction of a three-dimensional (3D) multimodal molecular atlas of colorectal cancer (CRC) across different ages of onset of the disease. We aim...

$10.63M
USD
Active NON-SBIR/STTR RPGS
Human Prostate Tumor Atlas Center
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2029

Project Summary Earlier gains in reducing prostate cancer (PCa) mortality, partially due to advances in screening and the use of androgen deprivation therapy to treat metastatic PC...

$10.33M
USD
Active NON-SBIR/STTR RPGS
Pre-cancer atlas of skin cancer
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

The overarching goal of our proposal is to develop a pre-cancer atlas of skin cancer. Skin is an ideal model to study the early phases of tumorigenesis because it is easily accessi...

$10.19M
USD
Active TRAINING, INDIVIDUAL
Genome-wide approaches to non-invasive screening and characterization of ovarian cancers
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2027

PROJECT SUMMARY Ovarian cancer is the deadliest gynecological cancer, in part because there is no widely used screening test and 80% of tumors are diagnosed at a late stage. Though...

$539.7K
USD
Active NON-SBIR/STTR RPGS
An atlas of pancreatic tumorigenesis in the context of altered DNA repair occurring in high-risk individuals
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Pancreatic Ductal Adenocarcinoma (PDAC) is on track to become the second leading cause of cancer related deaths in the United States. This dismal prognosis...

$10.35M
USD
Active NON-SBIR/STTR RPGS
Understanding the role of tumor microenvironment in low grade glioma progression to malignancy
NATIONAL CANCER INSTITUTE California Institute of Technology United States 2024 – 2029

ABSTRACT Our PCA research center brings together the UCLA Neurosurgery team with the Caltech spatial single cell team to construct a comparative spatial atlas of low-grade gliomas....

$10.69M
USD
Active OTHER RESEARCH-RELATED
The Role of Guanine Exchange Factors in Pancreatic Ductal Adenocarcinoma (PDAC)
NATIONAL CANCER INSTITUTE Wayne State University United States 2024 – 2026

Project Summary Pancreatic ductal adenocarcinoma (PDAC) is a cancer with a poor prognosis and limited treatment options. Multiple lines of evidence have shown that cancer cells fre...

$504.7K
USD
Active OTHER RESEARCH-RELATED
Investigating the Microenvironmental Dysregulation and Polypharmacy Impact during Acute Myeloid Leukemia in an in vitro model of the human bone marrow and in vivo models.
NATIONAL CANCER INSTITUTE University of Rochester United States 2024 – 2026

Project Summary and Abstract This award will support Azmeer Sharipol, M.S., long-term goal of developing the expertise and skills needed to become an independent investigator explo...

$399.6K
USD
Active NON-SBIR/STTR RPGS
Desmoplastic small round cell tumor: harnessing new insights and new models
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2029

The desmoplastic small round cell tumor (DSRCT) remains one of the most lethal adolescent/young adult (AYA) sarcomas. The EWSR1-WT1 gene fusion is the primary and defining genetic...

$5.28M
USD
Active OTHER RESEARCH-RELATED
PD-1 blockade effects on bone strength and metastatic progression
NATIONAL CANCER INSTITUTE Vanderbilt University United States 2024 – 2026

PROJECT SUMMARY Immune checkpoint inhibitors (ICIs) enable anti-tumor immunity by blocking immunoregulatory receptor-ligand interactions (e.g., programmed cell death protein 1 [PD-...

$358.7K
USD